Virtual health talk: Understanding lung cancer

Join us for an informative and powerful virtual talk on lung cancer, one of the most common and serious types of cancer worldwide. Areo Saffarzadeh, M.D., thoracic surgeon and director of Thoracic Robotic Surgery at Providence Cancer Institute, will lead this free talk to help deepen our understanding of lung cancer. The event is hosted by Asian Cancer Resource & Support Services and Providence Cancer Institute.

Here's what you’ll learn:

  • Key facts about lung cancer: types, how common it is and how it develops
  • Common risk factors and screening guidelines
  • Practical prevention and early detection strategies

This is a free event open to patients, caregivers and health care professionals.

Event Details

Understanding Lung Cancer: Facts, Risks and Prevention

Thursday, Aug. 21, 2025
10:00 a.m.
Via Zoom

Register today!

About Dr. Saffarzadeh

Dr. Areo Saffarzadeh is a thoracic surgeon and director of Thoracic Robotic Surgery at Providence Cancer Institute. He completed residency and fellowship training in thoracic surgery at Yale University after attending medical school at UC Irvine. Dr. Saffarzadeh specializes in minimally invasive surgery in the chest using robotic surgery. He has authored numerous publications and given presentations around the country on robotic chest surgery and methods to improve accurate diagnosis and outcomes in cancer treatment using new technologies.

Related news

Providence researchers share cancer discoveries at 2025 ASCO meeting

Clinical trials matter, just ask Randy

Providence Willamette Falls celebrates opening of new cancer center

Previous Article
Breast cancer prevention: Separating facts from myths
Breast cancer prevention: Separating facts from myths

Learn evidence-based breast cancer prevention strategies, find out the truth about common myths and discove...

Next Article
A new cancer therapy at Providence helps immune cells stand their ground
A new cancer therapy at Providence helps immune cells stand their ground

A new medication developed at Providence Cancer Institute is being evaluated in a clinical trial for people...